BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · IEX Real-Time Price · USD
81.83
-0.75 (-0.91%)
May 8, 2024, 4:00 PM EDT - Market closed

BioMarin Pharmaceutical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1997
Cash & Equivalents
755.13724.53587.28649.16437.45493.98598.03408.33397.04875.49
Upgrade
Short-Term Investments
318.68567.01426.6416.23316.36590.33797.94381.35195.5869.71
Upgrade
Cash & Cash Equivalents
1,0741,2921,0141,065753.811,0841,396789.68592.62945.19
Upgrade
Cash Growth
-16.86%27.39%-4.83%41.33%-30.48%-22.33%76.78%33.25%-37.30%20.45%
Upgrade
Receivables
633.7461.32373.4448.35377.4342.63261.37215.28164.96144.47
Upgrade
Inventory
1,107894.08776.67698.55680.28530.87475.78355.13271.68199.45
Upgrade
Other Current Assets
141.39104.52110.44129.93130.6698.474.0461.7160.38108.52
Upgrade
Total Current Assets
2,9562,7512,2742,3421,9422,0562,2071,4221,0901,398
Upgrade
Property, Plant & Equipment
1,0661,0731,0351,0321,011948.68896.7798.77704.21523.52
Upgrade
Long-Term Investments
611.14333.84507.79285.47411.98235.86385.79572.71425.6597.86
Upgrade
Goodwill and Intangibles
490.9534.77584.85613.47653.62688.85714.55750.82881.04210.84
Upgrade
Other Long-Term Assets
1,7171,6821,6021,574671.43497.52428.95479.6628.84245.53
Upgrade
Total Long-Term Assets
3,8863,6243,7303,5062,7482,3712,4262,6022,6401,078
Upgrade
Total Assets
6,8426,3756,0055,8484,6904,4274,6334,0243,7292,475
Upgrade
Accounts Payable
683.15572.96498.27492.55570.62437.29401.92370.51392.51231.84
Upgrade
Current Debt
493.88000361.880360.9522.4800
Upgrade
Other Current Liabilities
015.9348.230085.9553.6546.3352.953.9
Upgrade
Total Current Liabilities
1,177588.88546.5492.55932.5523.24816.52439.31445.46235.74
Upgrade
Long-Term Debt
593.11,0831,0791,075486.24830.42813.52660.76662.29642.9
Upgrade
Other Long-Term Liabilities
119.94100.02113.53174.33148.92105.53194.42157.34220.7868.84
Upgrade
Total Long-Term Liabilities
713.031,1831,1931,249635.16935.951,008818.11883.06711.75
Upgrade
Total Liabilities
1,8901,7721,7391,7421,5681,4591,8241,2571,329947.49
Upgrade
Total Debt
1,0871,0831,0791,075848.12830.421,174683.24662.29642.9
Upgrade
Debt Growth
0.36%0.37%0.37%26.77%2.13%-29.29%71.90%3.16%3.02%-1.93%
Upgrade
Retained Earnings
-621.55-789.2-930.76-861.61-1,720.71-1,694.13-1,637.55-1,520.51-1,021.57-849.77
Upgrade
Comprehensive Income
-28.79-3.8714.43-16.1420.165.27-22.9612.8221.0327.47
Upgrade
Shareholders' Equity
4,9524,6034,2664,1063,1222,9682,8092,7662,4011,528
Upgrade
Net Cash / Debt
-13.16208.52-65.2-9.76-94.31253.89221.5106.44-69.67302.29
Upgrade
Net Cash / Debt Growth
-----14.62%108.10%--134.05%
Upgrade
Net Cash Per Share
-0.071.10-0.36-0.05-0.531.431.270.64-0.442.07
Upgrade
Working Capital
1,7792,1631,7281,8501,0101,5331,391982.48644.181,162
Upgrade
Book Value Per Share
26.3624.8523.3322.7117.4416.7616.1016.6715.0010.44
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).